32 results
424B3
MBRX
Moleculin Biotech Inc
16 Feb 24
Prospectus supplement
5:19pm
candidate being tested;
willingness or availability of subjects to participate in our clinical trials (including due to the COVID-19 pandemic);
proximity … because of the COVID-19 pandemic and restrictions on travel or healthcare institution policies, negative publicity from adverse events
424B5
MBRX
Moleculin Biotech Inc
22 Dec 23
Prospectus supplement for primary offering
5:00pm
East, the COVID-19 pandemic, and the general supply chain shortages effects on our clinical trials, clinical drug candidate supplies, preclinical
8-K
EX-99.1
u4ts78
24 Mar 21
Moleculin Biotech, Inc. Reports Financial Results
7:31am